Skip to main content
Year archive

Anteris Technologies Global Corp. — 2023 filings

All 132 regulatory filings released by Anteris Technologies Global Corp. (AVR) in 2023, sourced directly from the official regulator.

132 Filings
2023 Period
2023 filings (132)
Filing Released Lang
Cleansing Notice 2 pages 155.7KB
Regulatory Filings
2023-12-21 English
Application for quotation of securities - AVR 8 pages 30.6KB
Regulatory Filings
2023-12-20 English
Update on Equity Raising 2 pages 187.4KB
Regulatory Filings
2023-12-14 English
Notification regarding unquoted securities - AVR 9 pages 33.8KB
Regulatory Filings
2023-11-27 English
Cleansing Notice 2 pages 208.2KB
Regulatory Filings
2023-11-21 English
30-day Haemodynamic Results from the DurAVR US EFS Trial 2 pages 245.4KB
Regulatory Filings
2023-11-20 English
Application for quotation of securities - AVR 8 pages 30.9KB
Regulatory Filings
2023-11-20 English
Change in substantial holding 4 pages 2.0MB
Regulatory Filings
2023-11-06 English
Application for quotation of securities - AVR 8 pages 30.8KB
Regulatory Filings
2023-11-02 English
Cleansing Notice 2 pages 235.3KB
Regulatory Filings
2023-11-02 English
Change in substantial holding 4 pages 246.7KB
Regulatory Filings
2023-11-02 English
Notification of cessation of securities - AVR 5 pages 26.3KB
Regulatory Filings
2023-10-31 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 436.7KB
Regulatory Filings
2023-10-30 English
Capital Raise 2 pages 222.0KB
Regulatory Filings
2023-10-25 English
Proposed issue of securities - AVR 5 pages 27.6KB
Regulatory Filings
2023-10-25 English
Reinstatement to Official Quotation 1 page 90.4KB
Regulatory Filings
2023-10-25 English
Cleansing Notice 2 pages 235.6KB
Regulatory Filings
2023-10-25 English
Suspension from Official Quotation 2 pages 620.3KB
Regulatory Filings
2023-10-24 English
Positive Results from Interim Analysis of DurAVR EFS Trial 3 pages 256.9KB
Regulatory Filings
2023-10-24 English
Application for quotation of securities - AVR 8 pages 30.6KB
Regulatory Filings
2023-10-23 English
Trading Halt 2 pages 641.6KB
Regulatory Filings
2023-10-22 English
Anteris Completes DurAVR THV EFS Enrolment 2 pages 246.7KB
Regulatory Filings
2023-10-16 English
R&D Refund 2 pages 237.3KB
Regulatory Filings
2023-10-12 English
Notification of cessation of securities - AVR 5 pages 25.7KB
Regulatory Filings
2023-10-05 English
Application for quotation of securities - AVR 8 pages 30.6KB
Regulatory Filings
2023-09-28 English
Cleansing Notice 2 pages 235.7KB
Regulatory Filings
2023-09-28 English
Change of Director's Interest Notice x 4 11 pages 374.5KB
Regulatory Filings
2023-09-19 English
Notification regarding unquoted securities - AVR 9 pages 34.7KB
Regulatory Filings
2023-09-18 English
Anteris to Present at Cantor Healthcare Conference 2 pages 218.9KB
Regulatory Filings
2023-09-11 English
Results of Meeting 3 pages 418.9KB
Regulatory Filings
2023-09-05 English
Cleansing Notice 2 pages 236.0KB
Regulatory Filings
2023-09-03 English
Application for quotation of securities - AVR 8 pages 30.6KB
Regulatory Filings
2023-08-31 English
Appendix 4D and Half Year Financial Report 26 pages 1.2MB
Regulatory Filings
2023-08-24 English
Appendix 4D and Half Year Financial Report Announcement 3 pages 193.3KB
Regulatory Filings
2023-08-24 English
Application for quotation of securities - AVR 8 pages 30.6KB
Regulatory Filings
2023-08-17 English
Cleansing Notice 2 pages 173.7KB
Regulatory Filings
2023-08-17 English
Exceptional Results in Second Valve-in-Valve Case 2 pages 156.9KB
Regulatory Filings
2023-08-13 English
Montefiore enrolls Patients in US Early Feasibility Study 4 pages 239.4KB
Regulatory Filings
2023-08-08 English
Commencement of American Depository Receipt Program 2 pages 175.7KB
Regulatory Filings
2023-08-08 English
Notification regarding unquoted securities - AVR 9 pages 33.7KB
Regulatory Filings
2023-08-08 English
Notification of cessation of securities - AVR 5 pages 25.7KB
Regulatory Filings
2023-08-08 English
Notice of Extraordinary General Meeting/Proxy Form 15 pages 804.4KB
Regulatory Filings
2023-08-06 English
DurAVR first successful implantation Valve-in-Valve 2 pages 163.3KB
Regulatory Filings
2023-07-30 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 401.2KB
Regulatory Filings
2023-07-27 English
Notification of cessation of securities - AVR 5 pages 25.6KB
Regulatory Filings
2023-07-19 English
Application for quotation of securities - AVR 9 pages 33.7KB
Regulatory Filings
2023-07-12 English
Cleansing Notice 2 pages 175.6KB
Regulatory Filings
2023-07-12 English
Application for quotation of securities - AVR 8 pages 30.6KB
Regulatory Filings
2023-06-28 English
Cleansing Notice 2 pages 175.5KB
Regulatory Filings
2023-06-28 English
Application for quotation of securities - AVR 8 pages 30.6KB
Regulatory Filings
2023-06-21 English
Cleansing Notice 2 pages 175.0KB
Regulatory Filings
2023-06-21 English
Ceasing to be a substantial holder from MUFG 4 pages 756.0KB
Regulatory Filings
2023-06-18 English
Becoming a substantial holder from MS 14 pages 852.0KB
Regulatory Filings
2023-06-15 English
Becoming a substantial holder from MUFG 19 pages 592.9KB
Regulatory Filings
2023-06-15 English
Ceasing to be a substantial holder from MS 7 pages 307.0KB
Regulatory Filings
2023-06-15 English
Ceasing to be a substantial holder from MS 6 pages 307.8KB
Regulatory Filings
2023-06-13 English
Ceasing to be a substantial holder from MUFG 3 pages 1.3MB
Regulatory Filings
2023-06-13 English
Latest Patient Group Show Best Results to Date at 30 Days 2 pages 191.2KB
Regulatory Filings
2023-06-12 English
Becoming a substantial holder from MS 14 pages 887.5KB
Regulatory Filings
2023-06-08 English
DurAVR THV Demonstrate Sustained Haemodynamics to 1 Year 2 pages 192.2KB
Regulatory Filings
2023-06-08 English
Becoming a substantial holder from MUFG 17 pages 925.4KB
Regulatory Filings
2023-06-08 English
Ceasing to be a substantial holder from MS 7 pages 374.7KB
Regulatory Filings
2023-06-06 English
Ceasing to be a substantial holder from MUFG 4 pages 834.7KB
Regulatory Filings
2023-06-06 English
Becoming a substantial holder from MS 14 pages 886.4KB
Regulatory Filings
2023-06-05 English
Becoming a substantial holder from MUFG 17 pages 848.9KB
Regulatory Filings
2023-06-05 English
Application for quotation of securities - AVR 8 pages 30.9KB
Regulatory Filings
2023-05-31 English
Notification regarding unquoted securities - AVR 9 pages 34.2KB
Regulatory Filings
2023-05-31 English
Change of Director's Interest Notice 3 pages 205.4KB
Regulatory Filings
2023-05-31 English
Notification regarding unquoted securities - AVR 9 pages 33.7KB
Regulatory Filings
2023-05-31 English
Ceasing to be a substantial holder from MUFG 4 pages 763.9KB
Regulatory Filings
2023-05-31 English
DurAVR Maintains Exceptional Results in New Patient Cohort 2 pages 165.1KB
Regulatory Filings
2023-05-30 English
Ceasing to be a substantial holder from MS 7 pages 337.7KB
Regulatory Filings
2023-05-30 English
Becoming a substantial holder from MS 14 pages 890.7KB
Regulatory Filings
2023-05-29 English
Notification of cessation of securities - AVR 6 pages 28.1KB
Regulatory Filings
2023-05-29 English
Becoming a substantial holder from MUFG 18 pages 1.0MB
Regulatory Filings
2023-05-29 English
Notice of Annual General Meeting Withdrawal of Resolutions 2 pages 204.0KB
Regulatory Filings
2023-05-28 English
AGM Chairman Address and CEO Presentation 88 pages 8.9MB
Regulatory Filings
2023-05-28 English
Results of Annual General Meeting 2 pages 328.8KB
Regulatory Filings
2023-05-28 English
FIH Results Presented at EuroPCR & Simultaneous Publication 2 pages 186.8KB
Regulatory Filings
2023-05-21 English
Ceasing to be a substantial holder from MUFG 3 pages 789.7KB
Regulatory Filings
2023-05-21 English
Becoming a substantial holder from MS 14 pages 870.4KB
Regulatory Filings
2023-05-18 English
Becoming a substantial holder from MUFG 21 pages 859.9KB
Regulatory Filings
2023-05-18 English
Ceasing to be a substantial holder from MS 6 pages 285.5KB
Regulatory Filings
2023-05-18 English
Ceasing to be a substantial holder from MS 8 pages 378.5KB
Regulatory Filings
2023-05-17 English
Ceasing to be a substantial holder from MUFG 6 pages 365.8KB
Regulatory Filings
2023-05-17 English
Additional Patent for Heart Valve Replacement Technology 2 pages 166.9KB
Regulatory Filings
2023-05-16 English
Becoming a substantial holder from MS 14 pages 870.7KB
Regulatory Filings
2023-05-11 English
Becoming a substantial holder from MUFG 19 pages 956.3KB
Regulatory Filings
2023-05-11 English
Ceasing to be a substantial holder from MS 11 pages 282.6KB
Regulatory Filings
2023-05-10 English
Ceasing to be a substantial holder from MUFG 9 pages 1.2MB
Regulatory Filings
2023-05-10 English
Application for quotation of securities - AVR 9 pages 33.6KB
Regulatory Filings
2023-05-04 English
Cleansing Notice 2 pages 174.7KB
Regulatory Filings
2023-05-04 English
Notice of Annual General Meeting/Proxy Form 28 pages 823.1KB
Regulatory Filings
2023-04-27 English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 293.5KB
Regulatory Filings
2023-04-23 English
Application for quotation of securities - AVR 12 pages 39.8KB
Regulatory Filings
2023-04-19 English
Cleansing Notice 2 pages 169.5KB
Regulatory Filings
2023-04-19 English
Application for quotation of securities - AVR 8 pages 30.2KB
Regulatory Filings
2023-04-19 English
Agreement to Develop New Heart Valve Repair Device 4 pages 247.3KB
Regulatory Filings
2023-04-18 English
Annual Report to shareholders 92 pages 3.4MB
Regulatory Filings
2023-04-13 English
Corporate Governance Statement and Appendix 4G 22 pages 1.7MB
Regulatory Filings
2023-04-13 English
Becoming a substantial holder from MUFG 18 pages 943.8KB
Regulatory Filings
2023-04-11 English
Patent for Transcatheter Heart Valve Replacement Technology 2 pages 149.3KB
Regulatory Filings
2023-04-11 English
Ceasing to be a substantial holder from MS 8 pages 444.1KB
Regulatory Filings
2023-04-10 English
Becoming a substantial holder for MS 13 pages 624.2KB
Regulatory Filings
2023-04-10 English
Ceasing to be a substantial holder from MUFG 4 pages 888.6KB
Regulatory Filings
2023-04-10 English
Becoming a substantial holder from MS 13 pages 655.5KB
Regulatory Filings
2023-04-03 English
Becoming a substantial holder from MUFG 18 pages 824.6KB
Regulatory Filings
2023-04-03 English
Becoming a substantial holder 4 pages 538.8KB
Regulatory Filings
2023-04-02 English
FDA Allows Manufacturing to Begin at Expanded Facility 2 pages 176.1KB
Regulatory Filings
2023-03-26 English
Presentation at NWR Virtual Healthcare Conference 33 pages 3.8MB
Regulatory Filings
2023-03-20 English
Notice of AGM Date and Closing of Nominations for Directors 2 pages 146.3KB
Regulatory Filings
2023-03-19 English
NWR Virtual Healthcare Conference 2 pages 176.6KB
Regulatory Filings
2023-03-19 English
Application for quotation of securities - AVR 9 pages 33.0KB
Regulatory Filings
2023-03-19 English
Preliminary Final Report 72 pages 1.2MB
Regulatory Filings
2023-02-27 English
Notification of cessation of securities - AVR 5 pages 25.7KB
Regulatory Filings
2023-02-26 English
Settlement of $35M Capital Raising Transaction 2 pages 206.2KB
Regulatory Filings
2023-02-14 English
Application for quotation of securities - AVR 8 pages 30.2KB
Regulatory Filings
2023-02-14 English
Notification regarding unquoted securities - AVR 8 pages 30.7KB
Regulatory Filings
2023-02-14 English
Cleansing Notice 2 pages 169.3KB
Regulatory Filings
2023-02-14 English
Change in substantial holding 4 pages 151.2KB
Regulatory Filings
2023-02-13 English
Notification of cessation of securities - AVR 5 pages 26.3KB
Regulatory Filings
2023-02-09 English
$35M Capital Raise 2 pages 175.5KB
Regulatory Filings
2023-02-08 English
Proposed issue of securities - AVR 8 pages 36.9KB
Regulatory Filings
2023-02-08 English
FDA Grants Expanded Approval for the DurAVR EFS 2 pages 201.1KB
Regulatory Filings
2023-02-08 English
Pause in Trading 1 page 112.0KB
Regulatory Filings
2023-02-06 English
Trading Halt 2 pages 247.0KB
Regulatory Filings
2023-02-06 English
Proposed $50 Million Capital Facility 2 pages 250.7KB
Regulatory Filings
2023-02-05 English
Notification regarding unquoted securities - AVR 9 pages 32.2KB
Regulatory Filings
2023-02-05 English
Pause in Trading 1 page 111.3KB
Regulatory Filings
2023-02-01 English
Trading Halt 2 pages 614.2KB
Regulatory Filings
2023-02-01 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 299.1KB
Regulatory Filings
2023-01-30 English
DurAVR First in Human Study 12 Month Results 3 pages 184.3KB
Regulatory Filings
2023-01-15 English